Brief: Active Biotech Q3 Operating Loss Narrows To SEK 8.3 Mln

Active Biotech AB publ

05/11/2020 06:49

Nov 5 (Reuters) - Active Biotech AB (publ)  ACTI.ST :
    * ACTIVE BIOTECH INTERIM REPORT JANUARY – SEPTEMBER 2020
    * Q3 OPERATING LOSS SEK 8.3 MILLION VERSUS LOSS SEK 9.3
MILLION
YEAR AGO

Source text for Eikon:  ID:nGNXbdtkdc 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))